カテゴリ： Infiniti Research TechNavio, 世界, 医療/バイオ

世界の抗生物質市場2023～2027：静脈内投与、経口、その他

■ 英語タイトル：Global Antibiotics Market 2023-2027

調査会社Technavio社が発行したリサーチレポート（データ管理コード：IRTNTR41323-23）■ 発行会社/調査会社：Technavio
■ 商品コード：IRTNTR41323-23
■ 発行日：2022年12月30日
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：163
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥380,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD4,000 ⇒換算￥608,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の抗生物質市場2023～2027：静脈内投与、経口、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Technavio社発行の当調査レポートは、世界の抗生物質市場規模が2022年から2027年まで年平均6.07%成長し、17066.66百万ドルに達すると予測しています。当レポートでは、抗生物質の世界市場について総合的に調査・分析を行い、エグゼクティブサマリー、市場状況、市場規模、過去の市場規模、ファイブフォース分析、投与経路別（静脈内投与、経口、その他）分析、製品別（広域抗生物質、ナロースペクトル抗生物質）分析、顧客状況、地域別状況（アジア太平洋、北米、ヨーロッパ、アメリカ、中国、インド、イギリス、日本、その他地域）分析、推進要因・課題・動向、企業状況、企業分析などの内容をまとめております。なお、参入企業情報として、Abbott Laboratories、AbbVie Inc.、Armata Pharmaceuticals Inc.、Aspen Pharmacare Holdings Ltd、Astellas Pharma Inc.、Aurobindo Pharma Ltd.、Bayer AG、F. Hoffmann La Roche Ltd.、Flynn Pharma Ltd.、GlaxoSmithKline Plc、Incepta Pharmaceuticals Ltd.、Johnson and Johnson、Lupin Ltd.、Mayne Pharma Group Ltd.などが含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模
・過去の市場規模
・ファイブフォース分析

・世界の抗生物質市場規模：投与経路別
- 静脈内投与の市場規模
- 経口投与の市場規模
- その他投与経路の市場規模

・世界の抗生物質市場規模：製品別
- 広域抗生物質の市場規模
- ナロースペクトル抗生物質の市場規模

・顧客状況

・地域別状況
- アジア太平洋の抗生物質市場規模
- 北米の抗生物質市場規模
- ヨーロッパの抗生物質市場規模
- アメリカの抗生物質市場規模
- 中国の抗生物質市場規模
- インドの抗生物質市場規模
- イギリスの抗生物質市場規模
- 日本の抗生物質市場規模
- その他地域の抗生物質市場規模

・推進要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益、価格、競争、プロモーションなどの主要なパラメーターの分析によって得られた複数のソースからのデータを、調査・統合・総括することにより、市場の全体像を詳しく提示します。主要な業界のインフルエンサーを特定することにより、多様な市場の側面を提供します。これらのデータは包括的​​で信頼性が高く、一次・二次の広範な研究の結果です。Technavio社の市場調査書は、確かな市場の成長を予測するための定性的、定量的調査を行い、完全な競争状況、そして詳細なベンダー選択方法と分析を提供します。

抗生物質の世界市場 2023-2027

Technavio社は抗生物質市場をモニターしており、2022年から2027年にかけて17,066.66百万ドルの成長が見込まれ、予測期間中のCAGRは6.07%で加速すると予測しています。当レポートでは、抗生物質市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析も提供しています。

当レポートでは、現在の世界市場のシナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、感染症の流行の高まり、様々な疾患とその治療に対する意識の高まり、特別な規制指定によって牽引されています。

Technavio社の抗生物質市場は以下のように分類されています：

・投与経路別：
– 静脈注射
– 経口剤
– その他

・製品別：
– 広域スペクトル抗生物質
– ナロースペクトル抗生物質

・地域別：
– アジア
– 北米
– ヨーロッパ
– その他の地域（ROW）

本調査では、今後数年間における抗生物質市場の成長を促進する主な要因の一つとして、戦略的提携と合併・買収（M&A）を挙げています。また、患者支援プログラム（PAPS）の存在や、抗生物質研究のための連邦政府や機関への資金提供の増加は、市場の大きな需要につながるでしょう。

Technavio社は、主要パラメータの分析を通じて、複数の情報源からのデータを調査、合成、要約することにより、市場の詳細な姿を提示します。

当レポートでは、抗生物質市場について以下の分野をカバーしています：
– 抗生物質市場のサイジング
– 抗生物質市場の予測
– 抗生物質市場の産業分析

Technavio社の確実なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、Abbott Laboratories, AbbVie Inc., Armata Pharmaceuticals Inc., Aspen Pharmacare Holdings Ltd, Astellas Pharma Inc., Aurobindo Pharma Ltd., Bayer AG, F. Hoffmann La Roche Ltd., Flynn Pharma Ltd., GlaxoSmithKline Plc, Incepta Pharmaceuticals Ltd., Johnson and Johnson, Lupin Ltd., Mayne Pharma Group Ltd., Melinta Therapeutics LLC, Merck KGaA, Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltdなどの企業情報が含まれています。また、抗生物質市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を練り、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートでは、主要ベンダーの分析に加え、包括的な市場およびベンダーの状況を掲載しています。

Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析を通じて、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細な姿を提示します。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Route of Administration
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global antibiotics market 2022 – 2027
o Exhibit 18: Historic Market Size – Data Table on Global antibiotics market 2022 – 2027 ($ million)
o 4.2 Product Segment Analysis 2022 – 2027
o Exhibit 19: Historic Market Size – Product Segment 2022 – 2027 ($ million)
o 4.3 Route of administration Segment Analysis 2022 – 2027
o Exhibit 20: Historic Market Size – Route of administration Segment 2022 – 2027 ($ million)
o 4.4 Geography Segment Analysis 2022 – 2027
o Exhibit 21: Historic Market Size – Geography Segment 2022 – 2027 ($ million)
o 4.5 Country Segment Analysis 2022 – 2027
o Exhibit 22: Historic Market Size – Country Segment 2022 – 2027 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product – Market share 2022-2027 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Broad-spectrum antibiotics – Market size and forecast 2022-2027
o Exhibit 34: Chart on Broad-spectrum antibiotics – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Broad-spectrum antibiotics – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Broad-spectrum antibiotics – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Broad-spectrum antibiotics – Year-over-year growth 2022-2027 (%)
o 6.4 Narrow-spectrum antibiotics – Market size and forecast 2022-2027
o Exhibit 38: Chart on Narrow-spectrum antibiotics – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Narrow-spectrum antibiotics – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Narrow-spectrum antibiotics – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Narrow-spectrum antibiotics – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Product
o Exhibit 42: Market opportunity by Product ($ million)
• 7 Market Segmentation by Route of Administration
o 7.1 Market segments
o Exhibit 43: Chart on Route of Administration – Market share 2022-2027 (%)
o Exhibit 44: Data Table on Route of Administration – Market share 2022-2027 (%)
o 7.2 Comparison by Route of Administration
o Exhibit 45: Chart on Comparison by Route of Administration
o Exhibit 46: Data Table on Comparison by Route of Administration
o 7.3 Intravenous – Market size and forecast 2022-2027
o Exhibit 47: Chart on Intravenous – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Data Table on Intravenous – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Chart on Intravenous – Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Intravenous – Year-over-year growth 2022-2027 (%)
o 7.4 Oral – Market size and forecast 2022-2027
o Exhibit 51: Chart on Oral – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Oral – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Oral – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Oral – Year-over-year growth 2022-2027 (%)
o 7.5 Others – Market size and forecast 2022-2027
o Exhibit 55: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Route of Administration
o Exhibit 59: Market opportunity by Route of Administration ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 63: Chart on Geographic comparison
o Exhibit 64: Data Table on Geographic comparison
o 9.3 Asia – Market size and forecast 2022-2027
o Exhibit 65: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.4 North America – Market size and forecast 2022-2027
o Exhibit 69: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.5 Europe – Market size and forecast 2022-2027
o Exhibit 73: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 81: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 China – Market size and forecast 2022-2027
o Exhibit 85: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.9 India – Market size and forecast 2022-2027
o Exhibit 89: Chart on India – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on India – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on India – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on India – Year-over-year growth 2022-2027 (%)
o 9.10 UK – Market size and forecast 2022-2027
o Exhibit 93: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 97: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 101: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 102: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 104: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 105: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 106: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 107: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 108: Abbott Laboratories – Overview
o Exhibit 109: Abbott Laboratories – Business segments
o Exhibit 110: Abbott Laboratories – Key news
o Exhibit 111: Abbott Laboratories – Key offerings
o Exhibit 112: Abbott Laboratories – Segment focus
o 12.4 AbbVie Inc.
o Exhibit 113: AbbVie Inc. – Overview
o Exhibit 114: AbbVie Inc. – Product / Service
o Exhibit 115: AbbVie Inc. – Key news
o Exhibit 116: AbbVie Inc. – Key offerings
o 12.5 Aspen Pharmacare Holdings Ltd
o Exhibit 117: Aspen Pharmacare Holdings Ltd – Overview
o Exhibit 118: Aspen Pharmacare Holdings Ltd – Business segments
o Exhibit 119: Aspen Pharmacare Holdings Ltd – Key offerings
o Exhibit 120: Aspen Pharmacare Holdings Ltd – Segment focus
o 12.6 Astellas Pharma Inc.
o Exhibit 121: Astellas Pharma Inc. – Overview
o Exhibit 122: Astellas Pharma Inc. – Product / Service
o Exhibit 123: Astellas Pharma Inc. – Key offerings
o 12.7 Aurobindo Pharma Ltd.
o Exhibit 124: Aurobindo Pharma Ltd. – Overview
o Exhibit 125: Aurobindo Pharma Ltd. – Product / Service
o Exhibit 126: Aurobindo Pharma Ltd. – Key offerings
o 12.8 Bayer AG
o Exhibit 127: Bayer AG – Overview
o Exhibit 128: Bayer AG – Business segments
o Exhibit 129: Bayer AG – Key offerings
o Exhibit 130: Bayer AG – Segment focus
o 12.9 F. Hoffmann La Roche Ltd.
o Exhibit 131: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 132: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 133: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 134: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 135: F. Hoffmann La Roche Ltd. – Segment focus
o 12.10 GlaxoSmithKline Plc
o Exhibit 136: GlaxoSmithKline Plc – Overview
o Exhibit 137: GlaxoSmithKline Plc – Business segments
o Exhibit 138: GlaxoSmithKline Plc – Key offerings
o Exhibit 139: GlaxoSmithKline Plc – Segment focus
o 12.11 Incepta Pharmaceuticals Ltd.
o Exhibit 140: Incepta Pharmaceuticals Ltd. – Overview
o Exhibit 141: Incepta Pharmaceuticals Ltd. – Product / Service
o Exhibit 142: Incepta Pharmaceuticals Ltd. – Key offerings
o 12.12 Johnson and Johnson
o Exhibit 143: Johnson and Johnson – Overview
o Exhibit 144: Johnson and Johnson – Business segments
o Exhibit 145: Johnson and Johnson – Key news
o Exhibit 146: Johnson and Johnson – Key offerings
o Exhibit 147: Johnson and Johnson – Segment focus
o 12.13 Lupin Ltd.
o Exhibit 148: Lupin Ltd. – Overview
o Exhibit 149: Lupin Ltd. – Product / Service
o Exhibit 150: Lupin Ltd. – Key news
o Exhibit 151: Lupin Ltd. – Key offerings
o 12.14 Mayne Pharma Group Ltd.
o Exhibit 152: Mayne Pharma Group Ltd. – Overview
o Exhibit 153: Mayne Pharma Group Ltd. – Business segments
o Exhibit 154: Mayne Pharma Group Ltd. – Key offerings
o Exhibit 155: Mayne Pharma Group Ltd. – Segment focus
o 12.15 Merck KGaA
o Exhibit 156: Merck KGaA – Overview
o Exhibit 157: Merck KGaA – Business segments
o Exhibit 158: Merck KGaA – Key news
o Exhibit 159: Merck KGaA – Key offerings
o Exhibit 160: Merck KGaA – Segment focus
o 12.16 Pfizer Inc.
o Exhibit 161: Pfizer Inc. – Overview
o Exhibit 162: Pfizer Inc. – Product / Service
o Exhibit 163: Pfizer Inc. – Key news
o Exhibit 164: Pfizer Inc. – Key offerings
o 12.17 Sanofi SA
o Exhibit 165: Sanofi SA – Overview
o Exhibit 166: Sanofi SA – Business segments
o Exhibit 167: Sanofi SA – Key news
o Exhibit 168: Sanofi SA – Key offerings
o Exhibit 169: Sanofi SA – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 170: Inclusions checklist
o Exhibit 171: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 172: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 173: Research methodology
o Exhibit 174: Validation techniques employed for market sizing
o Exhibit 175: Information sources
o 13.5 List of abbreviations
o Exhibit 176: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Product
Exhibits6: Executive Summary – Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global antibiotics market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Product Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Route of administration Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Product – Market share 2022-2027 (%)
Exhibits31: Data Table on Product – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Broad-spectrum antibiotics – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Broad-spectrum antibiotics – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Broad-spectrum antibiotics – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Broad-spectrum antibiotics – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Narrow-spectrum antibiotics – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Narrow-spectrum antibiotics – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Narrow-spectrum antibiotics – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Narrow-spectrum antibiotics – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Product ($ million)
Exhibits43: Chart on Route of Administration – Market share 2022-2027 (%)
Exhibits44: Data Table on Route of Administration – Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Route of Administration
Exhibits46: Data Table on Comparison by Route of Administration
Exhibits47: Chart on Intravenous – Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on Intravenous – Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on Intravenous – Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Intravenous – Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Oral – Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Oral – Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Oral – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Oral – Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits59: Market opportunity by Route of Administration ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on India – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on India – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on India – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on India – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits101: Market opportunity By Geographical Landscape ($ million)
Exhibits102: Impact of drivers and challenges in 2022 and 2027
Exhibits103: Overview on Criticality of inputs and Factors of differentiation
Exhibits104: Overview on factors of disruption
Exhibits105: Impact of key risks on business
Exhibits106: Vendors covered
Exhibits107: Matrix on vendor position and classification
Exhibits108: Abbott Laboratories – Overview
Exhibits109: Abbott Laboratories – Business segments
Exhibits110: Abbott Laboratories – Key news
Exhibits111: Abbott Laboratories – Key offerings
Exhibits112: Abbott Laboratories – Segment focus
Exhibits113: AbbVie Inc. – Overview
Exhibits114: AbbVie Inc. – Product / Service
Exhibits115: AbbVie Inc. – Key news
Exhibits116: AbbVie Inc. – Key offerings
Exhibits117: Aspen Pharmacare Holdings Ltd – Overview
Exhibits118: Aspen Pharmacare Holdings Ltd – Business segments
Exhibits119: Aspen Pharmacare Holdings Ltd – Key offerings
Exhibits120: Aspen Pharmacare Holdings Ltd – Segment focus
Exhibits121: Astellas Pharma Inc. – Overview
Exhibits122: Astellas Pharma Inc. – Product / Service
Exhibits123: Astellas Pharma Inc. – Key offerings
Exhibits124: Aurobindo Pharma Ltd. – Overview
Exhibits125: Aurobindo Pharma Ltd. – Product / Service
Exhibits126: Aurobindo Pharma Ltd. – Key offerings
Exhibits127: Bayer AG – Overview
Exhibits128: Bayer AG – Business segments
Exhibits129: Bayer AG – Key offerings
Exhibits130: Bayer AG – Segment focus
Exhibits131: F. Hoffmann La Roche Ltd. – Overview
Exhibits132: F. Hoffmann La Roche Ltd. – Business segments
Exhibits133: F. Hoffmann La Roche Ltd. – Key news
Exhibits134: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits135: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits136: GlaxoSmithKline Plc – Overview
Exhibits137: GlaxoSmithKline Plc – Business segments
Exhibits138: GlaxoSmithKline Plc – Key offerings
Exhibits139: GlaxoSmithKline Plc – Segment focus
Exhibits140: Incepta Pharmaceuticals Ltd. – Overview
Exhibits141: Incepta Pharmaceuticals Ltd. – Product / Service
Exhibits142: Incepta Pharmaceuticals Ltd. – Key offerings
Exhibits143: Johnson and Johnson – Overview
Exhibits144: Johnson and Johnson – Business segments
Exhibits145: Johnson and Johnson – Key news
Exhibits146: Johnson and Johnson – Key offerings
Exhibits147: Johnson and Johnson – Segment focus
Exhibits148: Lupin Ltd. – Overview
Exhibits149: Lupin Ltd. – Product / Service
Exhibits150: Lupin Ltd. – Key news
Exhibits151: Lupin Ltd. – Key offerings
Exhibits152: Mayne Pharma Group Ltd. – Overview
Exhibits153: Mayne Pharma Group Ltd. – Business segments
Exhibits154: Mayne Pharma Group Ltd. – Key offerings
Exhibits155: Mayne Pharma Group Ltd. – Segment focus
Exhibits156: Merck KGaA – Overview
Exhibits157: Merck KGaA – Business segments
Exhibits158: Merck KGaA – Key news
Exhibits159: Merck KGaA – Key offerings
Exhibits160: Merck KGaA – Segment focus
Exhibits161: Pfizer Inc. – Overview
Exhibits162: Pfizer Inc. – Product / Service
Exhibits163: Pfizer Inc. – Key news
Exhibits164: Pfizer Inc. – Key offerings
Exhibits165: Sanofi SA – Overview
Exhibits166: Sanofi SA – Business segments
Exhibits167: Sanofi SA – Key news
Exhibits168: Sanofi SA – Key offerings
Exhibits169: Sanofi SA – Segment focus
Exhibits170: Inclusions checklist
Exhibits171: Exclusions checklist
Exhibits172: Currency conversion rates for US$
Exhibits173: Research methodology
Exhibits174: Validation techniques employed for market sizing
Exhibits175: Information sources
Exhibits176: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 脈絡膜新生血管のグローバル市場：静脈内投与、硝子体内
  • 世界の全身性エリテマトーデス（SLE）治療薬市場予測2024年-2032年：薬効分類別（抗マラリア薬、非ステロイド性抗炎症薬（NSAIDS）、細胞障害性・免疫抑制薬、生物学的製剤、その他）、投与形態別（静脈内投与、皮下投与、経口投与）、地域別
  • 電子顕微鏡のグローバル市場2023-2027：半導体、ライフサイエンス、材料科学、ナノテクノロジー
  • 半導体パッケージング材料のグローバル市場2023-2027：有機基板、リードフレーム、ボンディングワイヤ、セラミックパッケージ、その他
  • スタチンのグローバル市場2023-2027：病院、診療所、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(IRTNTR41323-23 )"世界の抗生物質市場2023～2027：静脈内投与、経口、その他" (英文：Global Antibiotics Market 2023-2027)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。